Es gab 50 kürzliche Insider-Transaktionen für Oak Street Health, Inc. (OSH), darunter 16 Käufe und 31 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $38.45K und die gesamten Insider-Verkäufe auf $3.79B.
Bedeutende Insider mit kürzlicher Aktivität umfassen General Atlantic, L.p., Kusserow Paul B. K., Dorsey Cheryl. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — OSH
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2023-05-02 |
General Atlantic, L.p. |
10 Percent Owner |
Sonstige (Verkauf) |
61,384,475 |
$39.00 |
$2.39B |
- |
| 2023-05-02 |
Kusserow Paul B. K. |
Director |
Aktienrückgabe |
23,342 |
$21.00 |
$490.18K |
- |
| 2023-05-02 |
Dorsey Cheryl |
Director |
Aktienrückgabe |
29,484 |
$39.00 |
$1.15M |
- |
| 2023-05-02 |
Klapstein Julie D |
Director |
Aktienrückgabe |
31,684 |
$39.00 |
$1.24M |
- |
| 2023-05-02 |
Benjamin Regina M. |
Director |
Aktienrückgabe |
23,881 |
$39.00 |
$931.36K |
- |
| 2023-05-02 |
Kaushal Mohit |
Director |
Aktienrückgabe |
215,224 |
$39.00 |
$8.39M |
- |
| 2023-05-02 |
Pykosz Michael T |
Chief Executive Officer |
Aktienrückgabe |
1,585,677 |
$15.75 |
$24.97M |
- |
| 2023-05-02 |
Price Geoffrey M |
Chief Innovation Officer |
Aktienrückgabe |
1,080,970 |
$39.00 |
$42.16M |
- |
| 2023-05-02 |
Guenthner Robert |
Chief Legal Officer |
Aktienrückgabe |
49,000 |
$21.96 |
$1.08M |
- |
| 2023-05-02 |
Myers Griffin |
Chief Medical Officer |
Aktienrückgabe |
50,890 |
$15.75 |
$801.52K |
- |
| 2023-05-02 |
Cook Timothy M |
Chief Financial Officer |
Aktienrückgabe |
10,212 |
$21.00 |
$214.45K |
- |
| 2023-05-02 |
Keck Kim |
Director |
Aktienrückgabe |
94,960 |
$39.00 |
$3.7M |
- |
| 2023-05-02 |
Clem Brian |
Chief Operating Officer |
Aktienrückgabe |
569,826 |
$39.00 |
$22.22M |
- |
| 2023-05-02 |
Newlight Partners Lp |
10 Percent Owner |
Aktienrückgabe |
32,550,265 |
$39.00 |
$1.27B |
- |
| 2023-04-26 |
Newlight Partners Lp |
10 Percent Owner |
Schenkung (gegeben) |
80,000 |
- |
- |
- |
| 2023-04-23 |
Kusserow Paul B. K. |
Director |
RSU-Zuteilung |
5,140 |
- |
- |
480,013 |
| 2023-04-23 |
Dorsey Cheryl |
Director |
RSU-Zuteilung |
5,140 |
- |
- |
29,484 |
| 2023-04-23 |
Klapstein Julie D |
Director |
RSU-Zuteilung |
5,140 |
- |
- |
50,912 |
| 2023-04-23 |
Benjamin Regina M. |
Director |
RSU-Zuteilung |
5,140 |
- |
- |
23,872 |
| 2023-04-23 |
Kaushal Mohit |
Director |
RSU-Zuteilung |
5,140 |
- |
- |
215,005 |
| 2023-04-23 |
Keck Kim |
Director |
RSU-Zuteilung |
5,140 |
- |
- |
74,214 |
| 2023-04-20 |
Price Geoffrey M |
Chief Innovation Officer |
Schenkung (gegeben) |
1,080,970 |
- |
- |
- |
| 2023-04-18 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
50,000 |
$21.00 |
$1.05M |
1,882,609 |
| 2023-04-10 |
Price Geoffrey M |
Chief Innovation Officer |
Informierter Verkauf |
4,517 |
$38.82 |
$175.37K |
3,879,525 |
| 2023-04-10 |
Guenthner Robert |
Chief Legal Officer |
Informierter Verkauf |
3,169 |
$38.82 |
$123.03K |
489,270 |
| 2023-04-10 |
Cook Timothy M |
Chief Financial Officer |
Informierter Verkauf |
5,978 |
$38.82 |
$232.09K |
1,456,206 |
| 2023-04-04 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
50,000 |
$21.00 |
$1.05M |
1,932,609 |
| 2023-03-31 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
200,000 |
$21.00 |
$4.2M |
1,982,609 |
| 2023-03-24 |
Pykosz Michael T |
Chief Executive Officer |
Schenkung (gegeben) |
1,282,000 |
- |
- |
6,322,280 |
| 2023-03-21 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
50,000 |
$21.00 |
$1.05M |
2,432,609 |
| 2023-03-20 |
Price Geoffrey M |
Chief Innovation Officer |
RSU-Zuteilung |
5,611 |
- |
- |
3,884,042 |
| 2023-03-20 |
Guenthner Robert |
Chief Legal Officer |
RSU-Zuteilung |
47,699 |
- |
- |
492,439 |
| 2023-03-20 |
Cook Timothy M |
Chief Financial Officer |
RSU-Zuteilung |
92,592 |
- |
- |
1,462,184 |
| 2023-03-20 |
Clem Brian |
Chief Operating Officer |
RSU-Zuteilung |
101,010 |
- |
- |
569,778 |
| 2023-03-17 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
37,913 |
$21.00 |
$796.17K |
1,799,281 |
| 2023-03-16 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
79,858 |
$21.00 |
$1.68M |
1,837,194 |
| 2023-03-15 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
1,831 |
$21.00 |
$38.45K |
1,917,052 |
| 2023-03-15 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung |
1,831 |
$21.00 |
$38.45K |
3,880,262 |
| 2023-03-13 |
Pykosz Michael T |
Chief Executive Officer |
RSU-Zuteilung |
25,605 |
- |
- |
7,211,464 |
| 2023-03-13 |
Price Geoffrey M |
Chief Innovation Officer |
RSU-Zuteilung |
11,296 |
- |
- |
3,878,431 |
| 2023-03-13 |
Guenthner Robert |
Chief Legal Officer |
RSU-Zuteilung |
11,981 |
- |
- |
444,740 |
| 2023-03-13 |
Myers Griffin |
Chief Medical Officer |
RSU-Zuteilung |
2,852 |
- |
- |
2,900 |
| 2023-03-13 |
Cook Timothy M |
Chief Financial Officer |
RSU-Zuteilung |
17,458 |
- |
- |
1,369,592 |
| 2023-03-09 |
Guenthner Robert |
Chief Legal Officer |
Informierter Verkauf |
8,250 |
$35.43 |
$292.28K |
432,759 |
| 2023-03-07 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
50,000 |
$21.00 |
$1.05M |
1,918,883 |
| 2023-02-23 |
Price Geoffrey M |
Chief Innovation Officer |
Informierter Verkauf |
7,728 |
$35.48 |
$274.23K |
3,867,135 |
| 2023-02-23 |
Guenthner Robert |
Chief Legal Officer |
Informierter Verkauf |
2,518 |
$35.49 |
$89.35K |
441,009 |
| 2023-02-23 |
Cook Timothy M |
Chief Financial Officer |
Informierter Verkauf |
5,107 |
$35.48 |
$181.22K |
1,352,134 |
| 2023-02-22 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
122,985 |
$21.00 |
$2.58M |
1,968,883 |
| 2023-02-21 |
Price Geoffrey M |
Chief Innovation Officer |
Optionsausübung (Verkauf) |
50,000 |
$21.00 |
$1.05M |
2,091,868 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall